Cortese Katia, Giordano Francesca, Surace Enrico M, Venturi Consuelo, Ballabio Andrea, Tacchetti Carlo, Marigo Valeria
Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4358-64. doi: 10.1167/iovs.05-0834.
The authors took advantage of the Oa1 mutant mouse in combination with other albinism mouse models (i.e., Tyrosinase and membrane-associated transporter protein [Matp]) to study the function of Oa1, the gene mutated in ocular albinism type 1, in the RPE during development and after birth.
Enzyme activity and protein localization were analyzed by immunohistochemistry of tyrosinase (Tyr) in Oa1-null mice. Ultrastructural analysis and morphometry were performed by electron microscopy, of the RPE in Oa1-knockout mouse and double-mutant mice of Oa1 with either Tyr or Matp.
Differently from other albinism models, Tyr activity was not impaired in Oa1-/- eyes. Hypopigmentation of the RPE in Oa1-/- mice is due to a reduced number of melanosomes. Analysis of Oa1-/-;Tyr(c-2J)/Tyr(c-2J) and Oa1-/-;Matp(uw)/Matp(uw) double-knockout mice, which display a block at stages II and III of melanosome maturation, respectively, revealed that Oa1 controls the rate of melanosome biogenesis at early stages of the organellogenesis, whereas the control on the organelle size is exerted at the final stage of melanosome development (stage IV).
The findings indicate that Oa1 is involved in the regulation of melanosome maturation at two steps. Acting at early maturation stages, Oa1 controls the abundance of melanosomes in RPE cells. At later stages, Oa1 has a function in the maintenance of a correct melanosomal size. This study helps to define ocular albinism type 1 as a defect in melanosome organellogenesis and not in melanin production.
作者利用Oa1突变小鼠与其他白化病小鼠模型(即酪氨酸酶和膜相关转运蛋白[Matp])相结合,研究在1型眼白化病中发生突变的Oa1基因在视网膜色素上皮(RPE)发育期间及出生后的功能。
通过对Oa1基因敲除小鼠的酪氨酸酶(Tyr)进行免疫组织化学分析,来检测酶活性和蛋白质定位。利用电子显微镜对Oa1基因敲除小鼠以及Oa1与Tyr或Matp的双突变小鼠的RPE进行超微结构分析和形态测量。
与其他白化病模型不同,Oa1基因敲除小鼠眼中的Tyr活性并未受损。Oa1基因敲除小鼠RPE色素减退是由于黑素小体数量减少。对分别在黑素小体成熟的II期和III期出现阻滞的Oa1基因敲除;Tyr(c - 2J)/Tyr(c - 2J)和Oa1基因敲除;Matp(uw)/Matp(uw)双敲除小鼠的分析表明,Oa1在细胞器发生的早期阶段控制黑素小体生物合成的速率,而对细胞器大小的控制则在黑素小体发育的最后阶段(IV期)发挥作用。
研究结果表明,Oa1在两个步骤参与黑素小体成熟的调控。在成熟早期阶段,Oa1控制RPE细胞中黑素小体的丰度。在后期阶段,Oa1在维持黑素小体正确大小方面发挥作用。这项研究有助于将1型眼白化病定义为黑素小体细胞器发生缺陷而非黑色素生成缺陷。